DIH Holding US (NASDAQ:DHAI – Get Free Report) and NeuroPace (NASDAQ:NPCE – Get Free Report) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, dividends, earnings and risk.
Profitability
This table compares DIH Holding US and NeuroPace’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DIH Holding US | -13.59% | -5.07% | -25.97% |
| NeuroPace | -36.74% | -205.41% | -28.29% |
Analyst Ratings
This is a breakdown of recent ratings and price targets for DIH Holding US and NeuroPace, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DIH Holding US | 0 | 0 | 0 | 0 | 0.00 |
| NeuroPace | 0 | 1 | 4 | 0 | 2.80 |
Institutional & Insider Ownership
27.8% of DIH Holding US shares are held by institutional investors. Comparatively, 78.8% of NeuroPace shares are held by institutional investors. 49.6% of DIH Holding US shares are held by insiders. Comparatively, 22.2% of NeuroPace shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares DIH Holding US and NeuroPace”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DIH Holding US | $64.47 million | 0.11 | -$8.44 million | ($0.30) | -0.50 |
| NeuroPace | $79.91 million | 4.35 | -$32.96 million | ($0.95) | -11.23 |
DIH Holding US has higher earnings, but lower revenue than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than DIH Holding US, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
DIH Holding US has a beta of -0.17, suggesting that its stock price is 117% less volatile than the S&P 500. Comparatively, NeuroPace has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500.
About DIH Holding US
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.
About NeuroPace
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Receive News & Ratings for DIH Holding US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIH Holding US and related companies with MarketBeat.com's FREE daily email newsletter.
